4.7 Review

The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention

Journal

NATURE REVIEWS CANCER
Volume 12, Issue 3, Pages 181-195

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nrc3214

Keywords

-

Categories

Funding

  1. US National Institutes of Health [CA124533, CA126826, CA141029, CA140369, AA018863, R01CA148828]
  2. National Cancer Institute [ZIABC005561, ZIABC005562, ZIABC005708]

Ask authors/readers for more resources

Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that are involved in regulating glucose and lipid homeostasis, inflammation, proliferation and differentiation. Although all of these functions might contribute to the influence of PPARs in carcinogenesis, there is a distinct need for a review of the literature and additional experimentation to determine the potential for targeting PPARs for cancer therapy and cancer chemoprevention. As PPAR agonists include drugs that are used for the treatment of metabolic diseases, a more complete understanding of the roles of PPARs in cancer will aid in determining any increased cancer risk for patients undergoing therapy with PPAR agonists.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available